Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans

Anesthesia and Analgesia

Volumn 106, Issue 6, 2008, Pages 1749-1758

  Wacker, Johannes ^a   Lucchinetti, Eliana ^a   Jamnicki, Marina ^a   Aguirre, José ^a   Härter, Luc ^b   Keel, Marius ^b   Zaugg, Michael ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Department of Trauma Surgery ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; ONDANSETRON; OXYGEN; PADGEM PROTEIN; PURINERGIC P2Y12 RECEPTOR; SEVOFLURANE; THROMBIN RECEPTOR; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; ANTITHROMBOCYTIC AGENT; ETHER DERIVATIVE; GLYCOPROTEIN IIB; INHALATION ANESTHETIC AGENT; P2RY12 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PURINERGIC P2 RECEPTOR; THROMBIN RECEPTOR PEPTIDE (42 47); THROMBIN RECEPTOR PEPTIDE (42-47); THROMBOXANE A2 RECEPTOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN TISSUE; MALE; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE MEMBRANE; THROMBOELASTOGRAPHY; VENOUS BLOOD; BLOOD; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ADHESIVENESS; TIME;

ADENOSINE DIPHOSPHATE; ADMINISTRATION, INHALATION; ADULT; ANESTHETICS, INHALATION; ARACHIDONIC ACID; BLOOD COAGULATION; BLOOD PLATELETS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; MALE; METHYL ETHERS; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET ADHESIVENESS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET MEMBRANE GLYCOPROTEIN IIB; RECEPTORS, PURINERGIC P2; RECEPTORS, THROMBIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RESEARCH DESIGN; THROMBELASTOGRAPHY; TIME FACTORS;

EID: 44649186880     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318172f9e9     Document Type: Article

References (46)

1. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a doubleblinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27
2. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, ten Broecke PW, De Blier IG, Stockman BA, Rodrigus IE. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20
3. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Harter L, Keel M, Meier T, Zaugg M. Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007; 106:262-8
4. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004;100:707-21
5. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Schaub MC. Volatile anesthetics mimic cardiac preconditioning by priming the activation of mito KATP channels via multiple signaling pathways. Anesthesiology 2002;97:4-14
6. Lucchinetti E, Aguirre J, Feng J, Zhu M, Suter M, Spahn DR, Harter L, Zaugg M. Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers. Anesth Analg 2007;105:629-40
7. Horn NA, de Rossi L, Robitzsch T, Hecker KE, Hutschenreuter G, Rossaint R. The effects of sevoflurane and desflurane in vitro on platelet-leukocyte adhesion in whole blood. Anaesthesia 2003;58:312-9
8. Hirakata H, Nakamura K, Sai S, Okuda H, Hatano Y, Urabe N, Mori K. Platelet aggregation is impaired during anaesthesia with sevoflurane but not with isoflurane. Can J Anaesth 1997;44:1157-61
9. Horn NA, de Rossi L, Robitzsch T, Hecker KE, Hutschenreuter G, Rossaint R. Sevoflurane inhibits unstimulated and agonistinduced platelet antigen expression and platelet function in whole blood in vitro. Anesthesiology 2001;95:1220-5
10. Yokubol B, Hirakata H, Nakamura K, Sai S, Okuda H, Hatano Y, Urabe N, Mori K. Anesthesia with sevoflurane, but not isoflurane, prolongs bleeding time in humans. J Anesth 1999;13:193-6
11. Nozuchi S, Mizobe T, Aoki H, Hiramatsu N, Kageyama K, Amaya F, Uemura K, Fujimiya T. Sevoflurane does not inhibit human platelet aggregation induced by thrombin. Anesthesiology 2000;92:164-70
12. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, Handa S, Ogawa S. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995; 26:319-27
13. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995;91:37-45
14. Garcia C, Julier K, Bestmann L, Zollinger A, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth 2005;94:159-65
15. Linden MD, Whittaker P, Frelinger AL III, Barnard MR, Michelson AD, Przyklenk K. Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation. J Thromb Haemost 2006;4:2670-7
16. Zarbock A, Polanowska-Grabowska RK, Ley K. Plateletneutrophil- interactions: linking hemostasis and inflammation. Blood Rev 2007;21:99-111
17. Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998;88:572-8
18. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004;15:103-7
19. Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007;27:1511-20
20. Dogan IV, Ovali E, Eti Z, Yayci A, Gogus FY. The in vitro effects of isoflurane, sevoflurane, and propofol on platelet aggregation. Anesth Analg 1999;88:432-6
21. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC. Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology 1997;86:1128-39
22. Michelson AD. Evaluation of platelet function by flow cytometry. Pathophysiol Haemost Thromb 2006;35:67-82
23. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-83
24. Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007;100:1673-85
25. Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001;74:397-404
26. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyteendothelial and leukocyte-platelet interaction. Thromb Haemost 1999;81:1-7
27. Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, Cerletti C. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 1999;93:876-85
28. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996;94:1239-46
29. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 1996;28:345-53
30. Linden MD, Furman MI, Frelinger AL III, Fox ML, Barnard MR, Li Y, Przyklenk K, Michelson AD. Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 2007;5:761-5
31. Botto N, Sbrana S, Trianni G, Andreassi MG, Ravani M, Rizza A, Al-Jabri A, Palmieri C, Berti S. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon? Int J Cardiol 2007;117:123-30
32. Esposito CJ, Popescu WM, Rinder HM, Schwartz JJ, Smith BR, Rinder CS. Increased leukocyte-platelet adhesion in patients with graft occlusion after peripheral vascular surgery. Thromb Haemost 2003;90:1128-34
33. da Costa Martins P, Zwaginga JJ. Leukocyte-platelet aggregates: new particles reflecting and effecting cardiovascular disease. Thromb Haemost 2005;94:1120-1
34. Bonomini M, Stuard S, Carreno MP, Settefrati N, Santarelli P, Haeffner-Cavaillon N, Albertazzi A. Neutrophil reactive oxygen species production during hemodialysis: role of activated platelet adhesion to neutrophils through P-selectin. Nephron 1997;75:402-11
35. Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost 2005;3:254-67
36. Tanguay JF, Geoffroy P, Sirois MG, Libersan D, Kumar A, Schaub RG, Merhi Y. Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb Haemost 2004;91:1186 -93
37. Huang GS, Li CY, Hsu PC, Tsai CS, Lin TC, Wong CS. Sevoflurane anesthesia attenuates adenosine diphosphateinduced P-selectin expression and platelet-leukocyte conjugate formation. Anesth Analg 2004;99:1121-6
38. Beule AG, Wilhelmi F, Kuhnel TS, Hansen E, Lackner KJ, Hosemann W. Propofol versus sevoflurane: bleeding in endoscopic sinus surgery. Otolaryngol Head Neck Surg 2007;136: 45-50
39. Barazzone C, Tacchini-Cottier F, Vesin C, Rochat AF, Piguet PF. Hyperoxia induces platelet activation and lung sequestration: an event dependent on tumor necrosis factor-alpha and CD11a. Am J Respir Cell Mol Biol 1996;15:107-14
40. Postma S, Emara M, Obaid L, Johnson ST, Bigam DL, Cheung PY. Temporal platelet aggregatory function in hypoxic newborn piglets reoxygenated with 18%, 21%, and 100% oxygen. Shock 2007;27:448-54
41. Honemann CW, Nietgen GW, Podranski T, Chan CK, Durieux ME. Influence of volatile anesthetics on thromboxane A2 signaling. Anesthesiology 1998;88:440-51
42. Kohro S, Yamakage M. Direct inhibitory mechanisms of halothane on human platelet aggregation. Anesthesiology 1996;85: 96-106
43. McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC, Fitzgerald DJ. Integration of proteomics and genomics in platelets: a profile of platelet proteins and plateletspecific genes. Mol Cell Proteomics 2004;3:133-44
44. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci USA 1998;95:5556-61
45. Dropinski J, Jakiela B, Sanak M, Wegrzyn W, Biernat M, Dziedzina S, Plutecka H, Szczeklik A. The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin. Thromb Haemost 2007;98:201-9
46. Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL III, Michelson AD. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: effects of dalteparin or unfractionated heparin in combination with abciximab. Am Heart J 2001;142:790-8